Search
for
Sort by
Research 421–450 of 1000+
- A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study
- Spironolactone use does not increase the risk of female breast cancer recurrence: A retrospective analysis
- Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome
- Polymeric micelle mediated follicular delivery of spironolactone: Targeting the mineralocorticoid receptor to prevent glucocorticoid-induced activation and delayed cutaneous wound healing
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Use of spironolactone in dermatology.
- Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study
- Efficacy and safety profile of oral spironolactone use for androgenic alopecia: A systematic review.
- Spironolactone in dermatology: uses in acne and beyond
- Quantitative assessment of spironolactone treatment in women with diffuse androgen-dependent alopecia
- Spironolactone May Reduce the Risk of Incident Rosacea
- Testosterone, 17 Ks, 17 beta E2 FSH-LH variations and hirsutism modifications during spironolactone therapy.
- Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls
- Characterization of spironolactone and metabolites derivatized using Girard's reagent P using mass spectrometry and ion mobility spectrometry
- Spironolactone treatment for dermatologic indications is not associated with hypotension in a single-center retrospective study
- Spironolactone in dermatology
- Trends in the prescribing pattern of spironolactone for acne and hidradenitis suppurativa in adolescents
- A Comparative Study of Diane‐35 plus Spironolactone and Diane ‐35 Plus Finasteride in Cases of Hirsutism and Acne
- Spironolactone therapy in hypertrichosis
- Analyzing real-world adverse events of spironolactone with the FAERS database
- High-dose spironolactone for acne in patients with polycystic ovarian syndrome: A single-institution retrospective study
- Improving efficacy and maintaining safety in the treatment of alopecia with low-dose oral minoxidil and spironolactone combination therapy: A retrospective review
- Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease
- Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: A Prospective, Single-Center, Parallel-Group, Evaluator Blinded, Randomized Trial
- S125 Topical treatment of androgenetic alopecia with spironolactone
- Spironolactone therapy for hyperandrogenic anovulatory women--clinical and endocrinological study.
- Differential cardiometabolic outcomes of leuprolide versus spironolactone in women with polycystic ovary syndrome
- Case report: A pregnant woman accidental treated with spironolactone in mid-gestation
- Efficacy of spironolactone as adjunctive therapy to sodium valproate in bipolar‐I disorder: A double‐blind, randomized, placebo‐controlled clinical trial
- Topical Spironolactone in the Treatment of Evaporative Dry Eye Disease